ESC Position Paper on statins adherence and implementation of new lipid-lowering medications: barriers to be overcome.

Drexel, Heinz; Coats, Andrew J S; Spoletini, Ilaria; Bilato, Claudio; Mollace, Vincenzo; Filardi, Pasquale Perrone; Rosano, Giuseppe M C (2020). ESC Position Paper on statins adherence and implementation of new lipid-lowering medications: barriers to be overcome. European heart journal - cardiovascular pharmacotherapy, 6(2), pp. 115-121. Oxford University Press 10.1093/ehjcvp/pvz079

[img] Text
DrexelH_ESCPositionPaperonStatinAdherence_EurHeartJCardioPharm_2019.pdf - Accepted Version
Restricted to registered users only until 23 December 2020.
Available under License Publisher holds Copyright.

Download (963kB) | Request a copy

Benefits and safety on statins have been well established over 20 years of research. Despite this, the vast majority of patients are not adequately treated and do not achieve the low-density lipoprotein cholesterol target levels. This is mainly due to poor adherence, which is associated with dangerous and sometimes fatal outcomes. To increase adherence and prevent worse outcomes, a combination therapy with lower dosage of statins and new lipid lowering drugs may be used. However, the implementation of new lipid lowering drugs in European countries is still at the beginning. For these reasons, aim of this position paper is to give an up-to-date indication from the European Society of Cardiology in order to discuss the barriers towards statins adherence and new lipid lowering drugs implementation in Europe.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Drexel, Heinz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2055-6837

Publisher:

Oxford University Press

Language:

English

Submitter:

Isabel Lorenz

Date Deposited:

16 Jan 2020 09:48

Last Modified:

17 Mar 2020 01:32

Publisher DOI:

10.1093/ehjcvp/pvz079

PubMed ID:

31873726

Uncontrolled Keywords:

PCSK9 inhibitors Statins adherence ezetimibe low-density lipoprotein cholesterol position paper statin intolerance

BORIS DOI:

10.7892/boris.137824

URI:

https://boris.unibe.ch/id/eprint/137824

Actions (login required)

Edit item Edit item
Provide Feedback